Franklin Resources
CLSD

Franklin Resources’s Clearside Biomedical CLSD Stock Holding History

Franklin Resources’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,114
Closed -$85.9K – 2329
2022
Q4 		$85.9K Hold
5,114
– – ﹤0.01% 2150
2022
Q3 		$87K Buy
5,114
+45
+0.9% +$986 ﹤0.01% 2125
2022
Q2 		$112K Sell
5,069
-2,372
-32% -$57.6K ﹤0.01% 2131
2022
Q1 		$256K Hold
7,441
– – ﹤0.01% 2079
2021
Q4 		$307K Sell
7,441
-19
-0.3% -$1.23K ﹤0.01% 2072
2021
Q3 		$671K Buy
+7,460
New +$658K ﹤0.01% 1779

Other funds holding CLSD

CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Franklin Resources's CLSD Position: Q1 2023 in Review

Franklin Resources sold out of Clearside Biomedical (CLSD) in Q1 2023, closing a stake of 5,114 shares — an estimated $85.9K sold.

Franklin Resources first reported a position in CLSD in Q3 2021 and held it in 6 quarters. The position peaked at $671K in Q3 2021. 50 funds tracked by Wall St. Rank hold CLSD as of Q1 2023.

  • Franklin Resources reported no remaining Clearside Biomedical position as of Q1 2023 after selling out during the quarter.
  • Franklin Resources sold 5,114 Clearside Biomedical shares in Q1 2023, an estimated $85.9K.
  • Franklin Resources first reported a position in Clearside Biomedical in Q3 2021 and held it in 6 quarters.
  • Franklin Resources's Clearside Biomedical position peaked at $671K in Q3 2021.
  • 50 funds tracked by Wall St. Rank held Clearside Biomedical as of Q1 2023.

Based on Franklin Resources's 13F filing for Q1 2023, filed 12 May 2023.